TIGAR and acute lymphoblastic leukemia: In pediatric T-ALL, the downregulation of the oncogenic miR-652-5p reduces glucose metabolism in T-ALL cells by targeting TIGAR, slowing the growth of leukemia cells in vivo and in vitro [31].